Filing Details
- Accession Number:
- 0001093557-14-000057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-10 20:51:21
- Reporting Period:
- 2014-03-06
- Filing Date:
- 2014-03-10
- Accepted Time:
- 2014-03-10 20:51:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236388 | H Terrance Gregg | 6340 Sequence Drive San Diego CA 92121 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-03-06 | 8,000 | $8.95 | 220,813 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-06 | 8,000 | $47.51 | 212,813 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-03-06 | 12,500 | $6.85 | 225,313 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-06 | 12,500 | $48.02 | 212,813 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-03-08 | 182,813 | $0.00 | 395,626 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-03-06 | 12,500 | $48.02 | 12,500 | $6.85 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-03-06 | 8,000 | $47.51 | 8,000 | $8.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 736,108 | 2008-06-19 | 2017-06-19 | No | 4 | M | Direct |
| 370,000 | 2008-02-02 | 2018-01-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 11,461 | Indirect | by IRA |
| Common Stock | 712,889 | Indirect | by Trust |
Footnotes
- Included in this number are 182,813 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 126,954 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016.
- Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/36th shall vest each month beginning one month following the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
Billionaire Hedge Funds
